Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

OncoTargets and Therapy

Volumn 10, Issue , 2017, Pages 4809-4819

  Li, Shoushan ^a   Yan, Ting ^b   Deng, Rong ^c   Jiang, Xuesong ^c   Xiong, Huaping ^a   Wang, Yuan ^a   Yu, Qiao ^c   Wang, Xiaohua ^c   Chen, Cheng ^c   Zhu, Yichao ^b  

^a Traditional Chinese Medical Hospital of Siyang County   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c JIANGSU CANCER HOSPITAL   (China)

Author keywords

Invasion; Kaempferol; Migration; Rac1; RhoA; TNBC

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KAEMPFEROL; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LOW DRUG DOSE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; WOUND HEALING;

EID: 85031104881     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S140886     Document Type: Article

References (31)

1. Szekely B, Silber AL, Pusztai L. New therapeutic strategies for triple-negative breast cancer. Oncology (Williston Park). 2017;31(2):130–137.
2. Agarwal G, Nanda G, Lal P, et al. Outcomes of triple-negative breast cancers (TNBC) compared with non-TNBC: does the survival vary for all stages? World J Surg. 2016;40(6):1362–1372.
3. Dietze EC, Sistrunk C, Miranda-Carboni G, O’Regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015;15(4):248–254.
4. Bursts of chromosome changes drive TNBC. Cancer Discov. 2016;6(10):1075.
5. Rao KV, Seshadri TR. Synthesis of the monomethyl ethers of kae­mpferol, and the constitution of rhamnocitrin. J Chem Soc. 1947:122–124.
6. Li XM, Luo XG, Si CL, et al. Antibacterial active compounds from hypericum ascyron L. induce bacterial cell death through apoptosis pathway. Eur J Med Chem. 2015;96:436–444.
7. Jing P, Song LH, Shen SQ, Zhao SJ, Pang J, Qian BJ. Characterization of phytochemicals and antioxidant activities of red radish brines during lactic acid fermentation. Molecules. 2014;19(7):9675–9688.
8. Tang XL, Liu JX, Dong W, et al. Protective effect of kaempferol on LPS plus ATP-induced inflammatory response in cardiac fibroblasts. Inflammation. 2015;38(1):94–101.
9. Kashafi E, Moradzadeh M, Mohamadkhani A, Erfanian S. Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed Pharmacother. 2017;89:573–577.
10. Nguyen TT, Tran E, Ong CK, et al. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol. 2003;197(1):110–121.
11. Kuo WT, Tsai YC, Wu HC, et al. Radiosensitization of non-small cell lung cancer by kaempferol. Oncol Rep. 2015;34(5):2351–2356.
12. Nakamura Y, Chang CC, Mori T, et al. Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis. 2005;26(3):665–671.
13. Yoshida T, Konishi M, Horinaka M, et al. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun. 2008;375(1):129–133.
14. Choi EJ, Ahn WS. Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr Res Pract. 2008;2(4):322–325.
15. Kim SH, Hwang KA, Choi KC. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem. 2016;28:70–82.
16. Li C, Zhao Y, Yang D, et al. Inhibitory effects of kaempferol on the inva­sion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem Cell Biol. 2015;93(1):16–27.
17. Lee GA, Choi KC, Hwang KA. Kaempferol, a phytoestrogen, sup­pressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environ Toxicol Pharmacol. 2017;49:48–57.
18. Lu M, Wang T, He M, et al. Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer. Oncotarget. 2017;8(14):23008–23019.
19. Zhu Y, Tian Y, Du J, et al. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration. PLoS One. 2012;7(5):e37823.
20. Zhu Y, Shen T, Liu J, et al. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells. Cell Signal. 2013;25(5):1075–1085.
21. Liu J, Zhang Y, Xu R, et al. PI3K/Akt-dependent phosphorylation of GSK3beta and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell Signal. 2013;25(2):447–456.
22. Shan X, Wen W, Zhu D, et al. miR 1296–5p inhibits the migration and invasion of gastric cancer cells by repressing ERBB2 expression. PLoS One. 2017;12(1): e0170298.
23. Schettini F, Giuliano M, De Placido S, Arpino G. Nab-paclitaxel for the treatment of triple-negative breast cancer: rationale, clinical data and future perspectives. Cancer Treat Rev. 2016;50:129–141.
24. Kim BW, Lee ER, Min HM, et al. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol Ther. 2008;7(7):1080–1089.
25. Diantini A, Subarnas A, Lestari K, et al. Kaempferol-3-O-rhamnoside isolated from the leaves of schima wallichii Korth. inhibits MCF-7 breast cancer cell proliferation through activation of the caspase cascade pathway. Oncol Lett. 2012;3(5):1069–1072.
26. Ahmed S, Sami A, Xiang J. HER2-directed therapy: current treatment options for HER2-positive breast cancer. Breast Cancer. 2015;22(2):101–116.
27. Devi KP, Malar DS, Nabavi SF, et al. Kaempferol and inflammation: from chemistry to medicine. Pharmacol Res. 2015;99:1–10.
28. Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein func­tion and expression by kaempferol and quercetin. J Chemother. 2005;17(1):86–95.
29. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E. Kaemp­ferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther. 2007;6(9):2544–2553.
30. Qin Y, Cui W, Yang X, Tong B. Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2016;48(3):238–245.
31. Song H, Bao J, Wei Y, et al. Kaempferol inhibits gastric cancer tumor growth: an in vitro and in vivo study. Oncol Rep. 2015;33(2):868–874.